The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schutze, M. P.
Right arrow Articles by LeClerc, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schutze, M. P.
Right arrow Articles by LeClerc, C.

The Journal of Immunology, Vol 142, Issue 8 2635-2640, Copyright © 1989 by American Association of Immunologists


ARTICLES

Carrier-induced epitopic suppression is initiated through clonal dominance

MP Schutze, E Deriaud, G Przewlocki and C LeClerc
Laboratoire de Biologie des Regulations Immunitaires, Institut Pasteur, Paris, France.

Injection of mice with an immunogenic dose of carrier followed by immunization with hapten-carrier conjugate selectively suppresses anti- hapten antibody response. Previous studies have proposed that this epitopic suppression is related to the induction of carrier-specific Ts cells which in turn could inhibit selectively anti-hapten response. In the present study, we propose that the epitopic suppression is in fact due to clonal dominance. Immunization with a carrier such as tetanus toxoid induces a clonal expansion of carrier-specific B cells, thus decreasing the probability of hapten-specific B cells to react with the Ag. Increasing the density of the TNP-hapten on the conjugate has totally prevented the induction of the epitopic suppression. Moreover, using low hapten-carrier concentrations to challenge carrier-primed mice has enhanced the induction of the suppression. Finally, priming hapten-specific B cells before carrier/hapten-carrier immunization has also abrogated the suppression. The results of these experiments support the view that epitopic suppression is induced through the expansion of the clones specific for the carrier epitopes and resulted from intra-molecular antigenic competition between hapten and carrier epitopes. Based on these findings a regulatory role is proposed for B cells, where through their capacity to process and present antigen, they would exercise a strong influence on the selection of immune responses.


This article has been cited by other articles:


Home page
Int ImmunolHome page
T. Shimizu, Y. Osaka, C. Banri-Koike, M. Yoshida, K. Endo, K. Furukawa, M. Oda, A. Murakami, S. Ogawa, R. Abe, et al.
T cells specific to hapten carrier but not to carrier alone assist in the production of anti-hapten and anti-carrier antibodies
Int. Immunol., October 1, 2007; 19(10): 1157 - 1164.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. J. May, D. O. Beenhouwer, and M. D. Scharff
Antibodies to Keyhole Limpet Hemocyanin Cross-React with an Epitope on the Polysaccharide Capsule of Cryptococcus neoformans and Other Carbohydrates: Implications for Vaccine Development
J. Immunol., November 1, 2003; 171(9): 4905 - 4912.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. I. Stanisic, L. B. Martin, X. Q. Liu, D. Jackson, J. Cooper, and M. F. Good
Analysis of Immunological Nonresponsiveness to the 19-Kilodalton Fragment of Merozoite Surface Protein 1 of Plasmodium yoelii: Rescue by Chemical Conjugation to Diphtheria Toxoid (DT) and Enhancement of Immunogenicity by Prior DT Vaccination
Infect. Immun., October 1, 2003; 71(10): 5700 - 5713.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
L. Goetsch, J. F. Haeuw, T. Champion, C. Lacheny, T. N'Guyen, A. Beck, and N. Corvaia
Identification of B- and T-Cell Epitopes of BB, a Carrier Protein Derived from the G Protein of Streptococcus Strain G148
Clin. Vaccine Immunol., January 1, 2003; 10(1): 125 - 132.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. M. Li, L. D. Mayer, and M. B. Bally
Prevention of Antibody-Mediated Elimination of Ligand-Targeted Liposomes by Using Poly(Ethylene glycol)-Modified Lipids
J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 976 - 983.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Tsujihata, T. So, Y. Chijiiwa, Y. Hashimoto, M. Hirata, T. Ueda, and T. Imoto
Mutant Mouse Lysozyme Carrying a Minimal T Cell Epitope of Hen Egg Lysozyme Evokes High Autoantibody Response
J. Immunol., October 1, 2000; 165(7): 3606 - 3611.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
I. Rauly, L. Goetsch, J.-F. Haeuw, C. Tardieux, T. Baussant, J.-Y. Bonnefoy, and N. Corvaia
Carrier Properties of a Protein Derived from Outer Membrane Protein A of Klebsiella pneumoniae
Infect. Immun., November 1, 1999; 67(11): 5547 - 5551.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. L. Lohnas, S. F. Roberts, A. Pilon, and A. Tramontano
Epitope-Specific Antibody and Suppression of Autoantibody Responses Against a Hybrid Self Protein
J. Immunol., December 15, 1998; 161(12): 6518 - 6525.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Renjifo, S. Wolf, P.-P. Pastoret, H. Bazin, J. Urbain, O. Leo, and M. Moser
Carrier-Induced, Hapten-Specific Suppression: A Problem of Antigen Presentation?
J. Immunol., July 15, 1998; 161(2): 702 - 706.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. Dagan, J. Eskola, C. Leclerc, and O. Leroy
Reduced Response to Multiple Vaccines Sharing Common Protein Epitopes That Are Administered Simultaneously to Infants
Infect. Immun., May 1, 1998; 66(5): 2093 - 2098.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.